Preventing vertical virus infections: the role of serologic screening of pregnant women

Annemarie Berger; Hans Wilhelm Doerr

doi:10.1007/s00430-018-0549-y

Preventing vertical virus infections: the role of serologic screening of pregnant women

Med Microbiol Immunol. 2018 Nov;207(5-6):249-253. doi: 10.1007/s00430-018-0549-y. Epub 2018 Jul 3.

Authors

Annemarie Berger¹, Hans Wilhelm Doerr²

Affiliations

¹ Institut für Medizinische Virologie, Universitätsklinikum Frankfurt, Goethe Universität, Paul Ehrlich Str. 40, 60596, Frankfurt, Germany. Annemarie.Berger@em.uni-frankfurt.de.
² Institut für Medizinische Virologie, Universitätsklinikum Frankfurt, Goethe Universität, Paul Ehrlich Str. 40, 60596, Frankfurt, Germany.

PMID: 29971491
DOI: 10.1007/s00430-018-0549-y

Abstract

Several virus infections affect the pregnancy itself as well as the foetal development (rubella, PVB19, VZV, HSV, HCMV, HBV, HIV). Prevention can be established by vaccination or an assessment of the immunity status as well as by chemotherapy. The following review provides an update to current aspects focusing on the role of serologic screening.

Keywords: Pregnancy; Serologic screening; Vertical virus infections.

Publication types

Review

MeSH terms

Antiviral Agents / therapeutic use
Female
Humans
Infectious Disease Transmission, Vertical / prevention & control*
Mass Screening / methods*
Pregnancy
Pregnancy Complications, Infectious / diagnosis*
Serologic Tests / methods*
Vaccines / administration & dosage
Virus Diseases / diagnosis*
Virus Diseases / drug therapy
Virus Diseases / prevention & control
Virus Diseases / transmission*

Substances

Antiviral Agents
Vaccines